{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T14:43:32Z","timestamp":1782830612204,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12233-8","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:43:40Z","timestamp":1782827020000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["miR-4687-3p modulates cell proliferation and migration in cervical cancer cells"],"prefix":"10.1007","volume":"53","author":[{"given":"Iris","family":"Himal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kannan.","family":"S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5024-5730","authenticated-orcid":false,"given":"Anisha","family":"G. S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"12233_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"12233_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12978-024-01837-7","volume":"21","author":"T Ramamoorthy","year":"2024","unstructured":"Ramamoorthy T, Kulothungan V, Sathishkumar K, Tomy N, Mohan R, Balan S, Mathur P (2024) Burden of cervical cancer in India: estimates of years of life lost, years lived with disability and disability adjusted life years at national and subnational levels using the National Cancer Registry Programme data. Reproductive Health 21(1):111","journal-title":"Reproductive Health"},{"issue":"7","key":"12233_CR3","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3390\/medicina55070384","volume":"55","author":"SD Balasubramaniam","year":"2019","unstructured":"Balasubramaniam SD, Balakrishnan V, Oon CE, Kaur G (2019) Key Molecular Events in Cervical Cancer Development. Medicina 55(7):384","journal-title":"Medicina"},{"issue":"1","key":"12233_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13027-025-00677-9","volume":"20","author":"SM Khoshnazar","year":"2025","unstructured":"Khoshnazar SM, Salarizadeh N, Mohammad-Sadeghipour M, Shahpar A, Izadi M, Behzadnia MJ, Farhadi Khoozani M, Alimohammadi M, Farahani N, Hushmandi K (2025) Molecular interaction of human papilloma virus (HPV) with microRANs: insights into the development of cervical cancer and treatment approaches. Infect Agents Cancer 20(1):49","journal-title":"Infect Agents Cancer"},{"issue":"1","key":"12233_CR5","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s11033-024-09680-6","volume":"51","author":"N Balhara","year":"2024","unstructured":"Balhara N, Yadav R, Ranga S, Ahuja P, Tanwar M (2024) Understanding the HPV associated cancers: A comprehensive review. Mol Biol Rep 51(1):743","journal-title":"Mol Biol Rep"},{"issue":"11","key":"12233_CR6","doi-asserted-by":"publisher","first-page":"5865","DOI":"10.3390\/ijms25115865","volume":"25","author":"HH Wu","year":"2024","unstructured":"Wu HH, Leng S, Sergi C, Leng R (2024) How MicroRNAs Command the Battle against Cancer. Int J Mol Sci 25(11):5865","journal-title":"Int J Mol Sci"},{"issue":"5","key":"12233_CR7","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.3390\/ijms23052805","volume":"23","author":"B Smolarz","year":"2022","unstructured":"Smolarz B, Durczy\u0144ski A, Romanowicz H, Szy\u0142\u0142o K, Hogendorf P (2022) miRNAs in Cancer (Review of Literature). Int J Mol Sci 23(5):2805","journal-title":"Int J Mol Sci"},{"key":"12233_CR8","doi-asserted-by":"publisher","first-page":"1397945","DOI":"10.3389\/fcell.2024.1397945","volume":"12","author":"P Chauhan","year":"2024","unstructured":"Chauhan P, Pramodh S, Hussain A et al (2024) Understanding the role of miRNAs in cervical cancer pathogenesis and therapeutic responses. Front Cell Dev Biol 12:1397945","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"12233_CR9","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3390\/biomedicines13061457","volume":"13","author":"C P\u00e9rez-Plasencia","year":"2025","unstructured":"P\u00e9rez-Plasencia C, Orbe-Orihuela YC, M\u00e9ndez-Herrera A et al (2025) Regulatory Genetic Networks by microRNAs: Exploring Genomic Signatures in Cervical Cancer. Biomedicines 13(6):1457","journal-title":"Biomedicines"},{"key":"12233_CR10","doi-asserted-by":"publisher","first-page":"120641","DOI":"10.1016\/j.cca.2025.120641","volume":"579","author":"SN Mousavinejad","year":"2026","unstructured":"Mousavinejad SN, Lachouri R, Ferdosi F, Khatami SH (2026) Cervical cancer diagnostics: non-coding RNAs and biosensors to AI-derived methods. Clin Chim Acta 579:120641","journal-title":"Clin Chim Acta"},{"issue":"3","key":"12233_CR11","doi-asserted-by":"publisher","first-page":"e24398","DOI":"10.1016\/j.heliyon.2024.e24398","volume":"10","author":"HT Endale","year":"2024","unstructured":"Endale HT, Mariye YF, Negash HK, Hassen FS, Asrat WB, Mengstie TA, Tesfaye W (2024) miRNA in cervical cancer: Diagnosis to therapy: Systematic review. Heliyon 10(3):e24398","journal-title":"Heliyon"},{"key":"12233_CR12","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1007\/s12672-025-02744-4","volume":"16","author":"M Parvizi","year":"2025","unstructured":"Parvizi M, Vaezi M, Jeddi F, Bakhshandeh M, Eghdam-Zamiri R, Mobaraki-Asl N, Esmati E, Karimi A (2025) The role and diagnostic value of deregulated miRNAs in cervical cancer. Discover Oncol 16:922","journal-title":"Discover Oncol"},{"key":"12233_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13027-025-00677-9","volume":"20","author":"SM Khoshnazar","year":"2025","unstructured":"Khoshnazar SM, Salarizadeh N, Mohammad-Sadeghipour M, Shahpar A, Izadi M, Behzadnia MJ, Farhadi Khoozani M, Alimohammadi M, Farahani N, Hushmandi K (2025) Molecular interaction of human papilloma virus (HPV) with microRANs: insights into the development of cervical cancer and treatment approaches. Infect Agent Cancer 20:49","journal-title":"Infect Agent Cancer"},{"key":"12233_CR14","doi-asserted-by":"publisher","first-page":"105091","DOI":"10.1016\/j.critrevonc.2025.105091","volume":"218","author":"MT Costa","year":"2026","unstructured":"Costa MT, Tavares V, Adega F, Medeiros R (2026) Non-coding RNAs and liquid biopsies: Emerging biomarkers for cervical cancer. Crit Rev Oncol Hematol 218:105091","journal-title":"Crit Rev Oncol Hematol"},{"key":"12233_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.antiviral.2019.01.019","volume":"163","author":"L Sommerova","year":"2019","unstructured":"Sommerova L, Anton M, Bouchalova P, Jasickova H, Rak V, Jandakova E, Selingerova I, Bartosik M, Vojtesek B, Hrstka R (2019) The role of miR-409-3p in regulation of HPV16\/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions. Antiviral Res 163:185\u2013192","journal-title":"Antiviral Res"},{"key":"12233_CR16","doi-asserted-by":"publisher","first-page":"62914","DOI":"10.18632\/oncotarget.17516","volume":"8","author":"M Lin","year":"2017","unstructured":"Lin M, Xue X, Liang S-Z et al (2017) MiR187 overexpression inhibits cervical cancer progression by targeting HPV16 E6. Oncotarget 8:62914\u201362926","journal-title":"Oncotarget"},{"issue":"3","key":"12233_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41571-024-00977-w","volume":"22","author":"AA Francoeur","year":"2025","unstructured":"Francoeur AA, Monk BJ, Tewari KS (2025) Treatment advances across the cervical cancer spectrum. Nat Reviews Clin Oncol 22(3):182\u2013199","journal-title":"Nat Reviews Clin Oncol"},{"key":"12233_CR18","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/IGC.0000000000001203","volume":"28","author":"VB Nair","year":"2018","unstructured":"Nair VB, Manasa VG, Sinto MS, Jayasree K, James FV, Kannan S (2018) Differential Expression of MicroRNAs in Uterine Cervical Cancer and Its Implications in Carcinogenesis; An Integrative Approach. Int J Gynecol Cancer 28:553\u2013562","journal-title":"Int J Gynecol Cancer"},{"key":"12233_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/crst.crst_99_24","volume":"8","author":"V Maheshwari","year":"2025","unstructured":"Maheshwari V, Girotra S, Malik M, Basu S (2025) Prevalence and predictors of cervical cancer screening among married women in India: A cross-sectional analysis of National Family Health Survey-5 data. Cancer Res Stat Treat 8:30\u201338","journal-title":"Cancer Res Stat Treat"},{"key":"12233_CR20","first-page":"229","volume":"112","author":"A Buskwofie","year":"2020","unstructured":"Buskwofie A, David-West G, Clare CA (2020) A Review of Cervical Cancer: Incidence and Disparities. J Natl Med Assoc 112:229\u2013232","journal-title":"J Natl Med Assoc"},{"key":"12233_CR21","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1002\/jcp.27486","volume":"234","author":"K Saliminejad","year":"2019","unstructured":"Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH (2019) An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J Cell Physiol 234:5451\u20135465","journal-title":"J Cell Physiol"},{"issue":"1","key":"12233_CR22","first-page":"10","volume":"8","author":"AL Leit\u00e3o","year":"2022","unstructured":"Leit\u00e3o AL, Enguita FJ (2022) A Structural View of miRNA Biogenesis and Function. Noncoding RNA 8(1):10","journal-title":"Noncoding RNA"},{"key":"12233_CR23","first-page":"597508","volume":"11","author":"M Liu","year":"2020","unstructured":"Liu M, Si Q, Ouyang S et al (2020) Serum miR-4687-3p as the diagnostic biomarker for NSCLC. media sparx-ip net 11:597508","journal-title":"media sparx-ip net"},{"key":"12233_CR24","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1111\/cas.16150","volume":"115","author":"R Sonobe","year":"2024","unstructured":"Sonobe R, Yang P, Suzuki MM, Shinjo K, Iijima K, Nishiyama N, Miyata K, Kataoka K, Kajiyama H, Kondo Y (2024) Long noncoding RNA TUG1 promotes cisplatin resistance in ovarian cancer via upregulation of DNA polymerase eta. Cancer Sci 115:1910\u20131923","journal-title":"Cancer Sci"},{"issue":"1","key":"12233_CR25","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1038\/s41467-018-06434-4","volume":"9","author":"A Yokoi","year":"2018","unstructured":"Yokoi A, Matsuzaki J, Yamamoto Y et al (2018) Integrated extracellular microRNA profiling for ovarian cancer screening. Nat Commun 9(1):4319","journal-title":"Nat Commun"},{"key":"12233_CR26","doi-asserted-by":"publisher","first-page":"401","DOI":"10.26502\/fjhs.202","volume":"7","author":"A Khera","year":"2024","unstructured":"Khera A, Singh Pandav S, Ram J, Thattaruthody F, Chawla Gupta P (2024) Explicating the Role of miR-638 in the Pathogenesis of Exfoliation Syndrome and Exfoliation Glaucoma. Fortune J Health Sci 7:401\u2013407","journal-title":"Fortune J Health Sci"},{"issue":"1","key":"12233_CR27","doi-asserted-by":"publisher","first-page":"17051","DOI":"10.1038\/s41598-022-20338-w","volume":"12","author":"TM Popov","year":"2022","unstructured":"Popov TM, Stancheva G, Kyurkchiyan SG, Petkova V, Panova S, Kaneva RP, Popova DP (2022) Global microRNA expression profile in laryngeal carcinoma unveils new prognostic biomarkers and novel insights into field cancerization. Sci Rep 12(1):17051","journal-title":"Sci Rep"},{"key":"12233_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ncrna.2025.11.002","volume":"16","author":"A Jabri","year":"2025","unstructured":"Jabri A, Mhannayeh A, Alsharif M et al (2025) Integrative analysis of tissue and circulating miRNAs as biomarkers for progression and survival in hepatocellular carcinoma. Non-coding RNA Res 16:167\u2013177","journal-title":"Non-coding RNA Res"},{"key":"12233_CR29","doi-asserted-by":"publisher","first-page":"e0312754","DOI":"10.1371\/journal.pone.0312754","volume":"20","author":"Z Chaharlashkar","year":"2025","unstructured":"Chaharlashkar Z, Honar YS, Abdollahpour-Alitappeh M, Parvizpour S, Barzegar A, Alizadeh E (2025) Metastatic melanoma: An integrated analysis to identify critical regulators associated with prognosis, pathogenesis and targeted therapies. PLoS ONE 20:e0312754","journal-title":"PLoS ONE"},{"issue":"3","key":"12233_CR30","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1245\/s10434-015-4586-0","volume":"22","author":"K Zhang","year":"2015","unstructured":"Zhang K, Zhao S, Wang Q, Yang HS, Zhu J, Ma R (2015) Identification of microRNAs in Nipple Discharge as Potential Diagnostic Biomarkers for Breast Cancer. Ann Surg Oncol 22(3):536\u2013544","journal-title":"Ann Surg Oncol"},{"key":"12233_CR31","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.tig.2025.06.005","volume":"41","author":"A Robles-Remacho","year":"2025","unstructured":"Robles-Remacho A, Zou Y, Grillo M, Nilsson M (2025) Spatially resolved microRNA expression in tissues: technologies, challenges, and opportunities. Trends Genet 41:1131\u20131143","journal-title":"Trends Genet"},{"key":"12233_CR32","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1093\/nar\/gkw116","volume":"44","author":"N Ludwig","year":"2016","unstructured":"Ludwig N, Leidinger P, Becker K et al (2016) Distribution of miRNA expression across human tissues. Nucleic Acids Res 44:3865\u20133877","journal-title":"Nucleic Acids Res"},{"key":"12233_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13000-021-01182-4","volume":"17","author":"L Wu","year":"2022","unstructured":"Wu L, Shen B, Li J, Zhang H, Zhang K, Yang Y, Zu Z, Shen D, Luo M (2022) STAT3 exerts pro-tumor and anti-autophagy roles in cervical cancer. Diagn Pathol 17:13","journal-title":"Diagn Pathol"},{"key":"12233_CR34","doi-asserted-by":"publisher","first-page":"e67849","DOI":"10.1371\/journal.pone.0067849","volume":"8","author":"S Shukla","year":"2013","unstructured":"Shukla S, Mahata S, Shishodia G, Pandey A, Tyagi A, Vishnoi K, Basir SF, Das BC, Bharti AC (2013) Functional Regulatory Role of STAT3 in HPV16-Mediated Cervical Carcinogenesis. PLoS ONE 8:e67849","journal-title":"PLoS ONE"},{"key":"12233_CR35","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11010-009-0133-2","volume":"330","author":"RC Sobti","year":"2009","unstructured":"Sobti RC, Singh N, Hussain S, Suri V, Bharti AC, Das BC (2009) Overexpression of STAT3 in HPV-mediated cervical cancer in a north Indian population. Mol Cell Biochem 330:193\u2013199","journal-title":"Mol Cell Biochem"},{"key":"12233_CR36","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/oncolo\/oyae071","volume":"29","author":"AA Mcbride","year":"2024","unstructured":"Mcbride AA (2024) Human malignancies associated with persistent HPV infection. Oncologist 29:457\u2013464","journal-title":"Oncologist"},{"key":"12233_CR37","doi-asserted-by":"publisher","first-page":"8467","DOI":"10.63682\/jns.v14i32S.9162","volume":"14","author":"S Gupta","year":"2025","unstructured":"Gupta S (2025) Prevalence, Incidence and Mortality Rates of Cervical Cancer in India: based on Global Burden. J Neonatal Surg 14:8467\u20138500","journal-title":"J Neonatal Surg"},{"issue":"24","key":"12233_CR38","doi-asserted-by":"publisher","first-page":"13352","DOI":"10.3390\/ijms222413352","volume":"22","author":"M Ling","year":"2021","unstructured":"Ling M, Quan L, Lai X et al (2021) Vegfb promotes myoblasts proliferation and differentiation through vegfr1-pi3k\/akt signaling pathway. Int J Mol Sci 22(24):13352","journal-title":"Int J Mol Sci"},{"issue":"7","key":"12233_CR39","first-page":"e1328336","volume":"6","author":"M Dankner","year":"2017","unstructured":"Dankner M, Gray-Owen SD, Huang YH, Blumberg RS, Beauchemin N (2017) CEACAM1 as a multi-purpose target for cancer immunotherapy. Oncoimmunology 6(7):e1328336","journal-title":"Oncoimmunology"},{"key":"12233_CR40","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccr.2014.07.010","volume":"26","author":"Y Wang","year":"2014","unstructured":"Wang Y, Chen D, Qian H, Tsai YS, Shao S, Liu Q, Dominguez D, Wang Z (2014) The Splicing Factor RBM4 Controls Apoptosis, Proliferation, and Migration to Suppress Tumor Progression. Cancer Cell 26:374\u2013389","journal-title":"Cancer Cell"},{"key":"12233_CR41","doi-asserted-by":"crossref","unstructured":"Gao S, Gao X, Wang N, Xie Y, Tang Y (2025) MYO9B deficiency promoted head and neck tumor progression through HIF1\u03b1\/MYC\/STAT2 signaling pathway. Biochimica et Biophysica Acta (BBA) - General Subjects 1869:130834","DOI":"10.1016\/j.bbagen.2025.130834"},{"issue":"3","key":"12233_CR42","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s12013-019-00876-3","volume":"77","author":"CH Wang","year":"2019","unstructured":"Wang CH, Wang LK, Wu CC, Chen ML, Lee MC, Lin YY, Tsai FM (2019) The Ribosomal Protein RPLP0 Mediates PLAAT4-induced Cell Cycle Arrest and Cell Apoptosis. Cell Biochem Biophys 77(3):253\u2013260","journal-title":"Cell Biochem Biophys"},{"issue":"1","key":"12233_CR43","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1186\/s12885-023-11088-7","volume":"23","author":"Y Han","year":"2023","unstructured":"Han Y, Wang X, Xu M et al (2023) Aspartoacylase promotes the process of tumour development and is associated with immune infiltrates in gastric cancer. BMC Cancer 23(1):604","journal-title":"BMC Cancer"},{"issue":"1","key":"12233_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40779-023-00460-0","volume":"10","author":"H Weng","year":"2023","unstructured":"Weng H, Xiong KP, Wang W et al (2023) Aspartoacylase suppresses prostate cancer progression by blocking LYN activation. Military Med Res 10(1):25","journal-title":"Military Med Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12233-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12233-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12233-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:43:51Z","timestamp":1782827031000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12233-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12233"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12233-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1065"}}